BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30362094)

  • 1. NANOG-Dependent Metabolic Reprogramming and Symmetric Division in Tumor-Initiating Stem-like Cells.
    Machida K
    Adv Exp Med Biol; 2018; 1032():105-113. PubMed ID: 30362094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR4-dependent tumor-initiating stem cell-like cells (TICs) in alcohol-associated hepatocellular carcinogenesis.
    Machida K; Feldman DE; Tsukamoto H
    Adv Exp Med Biol; 2015; 815():131-44. PubMed ID: 25427905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs.
    Choi HY; Siddique HR; Zheng M; Kou Y; Yeh DW; Machida T; Chen CL; Uthaya Kumar DB; Punj V; Winer P; Pita A; Sher L; Tahara SM; Ray RB; Liang C; Chen L; Tsukamoto H; Machida K
    Nat Commun; 2020 Jun; 11(1):3084. PubMed ID: 32555153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.
    Uthaya Kumar DB; Chen CL; Liu JC; Feldman DE; Sher LS; French S; DiNorcia J; French SW; Naini BV; Junrungsee S; Agopian VG; Zarrinpar A; Machida K
    Gastroenterology; 2016 Mar; 150(3):707-19. PubMed ID: 26582088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus.
    Machida K; Chen CL; Liu JC; Kashiwabara C; Feldman D; French SW; Sher L; Hyeongnam JJ; Tsukamoto H
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):19-22. PubMed ID: 22320911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.
    Siddique HR; Feldman DE; Chen CL; Punj V; Tokumitsu H; Machida K
    Hepatology; 2015 Nov; 62(5):1466-79. PubMed ID: 26174965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell fate, metabolic reprogramming and lncRNA of tumor-initiating stem-like cells induced by alcohol.
    Machida K
    Chem Biol Interact; 2020 May; 323():109055. PubMed ID: 32171851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.
    Chen CL; Uthaya Kumar DB; Punj V; Xu J; Sher L; Tahara SM; Hess S; Machida K
    Cell Metab; 2016 Jan; 23(1):206-19. PubMed ID: 26724859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
    Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
    J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOTCH localizes to mitochondria through the TBC1D15-FIS1 interaction and is stabilized via blockade of E3 ligase and CDK8 recruitment to reprogram tumor-initiating cells.
    Choi HY; Zhu Y; Zhao X; Mehta S; Hernandez JC; Lee JJ; Kou Y; Machida R; Giacca M; Del Sal G; Ray R; Eoh H; Tahara SM; Chen L; Tsukamoto H; Machida K
    Exp Mol Med; 2024 Feb; 56(2):461-477. PubMed ID: 38409448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TBC1D15 oncoprotein controls stem cell self-renewal through destabilization of the Numb-p53 complex.
    Feldman DE; Chen C; Punj V; Machida K
    PLoS One; 2013; 8(2):e57312. PubMed ID: 23468968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol, TLR4-TGF-β antagonism, and liver cancer.
    Tsukamoto H; Mishra L; Machida K
    Hepatol Int; 2014 Sep; 8 Suppl 2(Suppl 2):408-12. PubMed ID: 26201318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133
    Liu K; Hao M; Ouyang Y; Zheng J; Chen D
    Sci Rep; 2017 Jan; 7():41499. PubMed ID: 28134312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes.
    Kwon YC; Bose SK; Steele R; Meyer K; Di Bisceglie AM; Ray RB; Ray R
    J Virol; 2015 Nov; 89(22):11549-56. PubMed ID: 26355082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
    Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
    Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
    Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog.
    Cao J; Zhao M; Liu J; Zhang X; Pei Y; Wang J; Yang X; Shen B; Zhang J
    Theranostics; 2019; 9(3):811-828. PubMed ID: 30809310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
    Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
    Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B e antigen and its precursors promote the progress of hepatocellular carcinoma by interacting with NUMB and decreasing p53 activity.
    Liu D; Cui L; Wang Y; Yang G; He J; Hao R; Fan C; Qu M; Liu Z; Wang M; Chen L; Li H; Guo D
    Hepatology; 2016 Aug; 64(2):390-404. PubMed ID: 27106262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation.
    Shao M; Yang Q; Zhu W; Jin H; Wang J; Song J; Kong Y; Lv X
    Mol Cancer; 2018 Dec; 17(1):173. PubMed ID: 30545354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.